MCED Medical Affairs Intern - Summer 2026 jobs in United States
cer-icon
Apply on Employer Site
company-logo

Exact Sciences · 2 days ago

MCED Medical Affairs Intern - Summer 2026

Exact Sciences is dedicated to changing how the world prevents, detects, and guides treatment for cancer. They are seeking a MCED Medical Affairs Intern to gain hands-on experience in medical affairs while collaborating with the Director of Medical Affairs for MCED on various initiatives.

BiotechnologyHealth DiagnosticsManufacturingMedical

Responsibilities

Collaborate with medical affairs on various initiatives including publications, advisory boards, medical education opportunities, training, and speaker development
Support the medical community, as needed, with up-to-date medical information and product information
Generate a key opinion leader (KOL) engagement strategy for MCED that maps, identifies, profiles and prioritizes thought leaders and establish key performance indicators/metrics
Communicate clinical insights on new data to the MCED Medical Affairs team to inform a key opinion leader engagement strategy
Identify potential KOLs and related external activities that would be valuable to the MCED program
Regular and reliable attendance

Qualification

Biological sciencesMedical affairsMicrosoft WordMicrosoft ExcelMicrosoft PowerPointCommunication skills

Required

Currently enrolled in a Bachelor's degree program in biology, chemistry, pharmacy, or other medical-related discipline
Basic proficiency with Microsoft Word, Excel and PowerPoint
Demonstrated ability to perform the Essential Duties of the position with or without accommodation
Strong communication skills

Benefits

Paid time off (including days for vacation, holidays, volunteering, and personal time)
Paid leave for parents and caregivers
A retirement savings plan
Wellness support
Health benefits including medical, prescription drug, dental, and vision coverage

Company

Exact Sciences

company-logo
Exact Sciences offers a portfolio of cancer screening and diagnostic tests that span from early detection to treatment monitoring.

Funding

Current Stage
Public Company
Total Funding
$2.75B
2025-06-20Acquired
2024-04-11Post Ipo Debt· $620.7M
2023-02-23Post Ipo Debt· $500M

Leadership Team

leader-logo
Kevin Conroy
Chairman & CEO
linkedin
leader-logo
Aaron Bloomer
Executive Vice President, CFO
linkedin
Company data provided by crunchbase